These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 23708663)
21. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Montaner S; Sodhi A; Pece S; Mesri EA; Gutkind JS Cancer Res; 2001 Mar; 61(6):2641-8. PubMed ID: 11289142 [TBL] [Abstract][Full Text] [Related]
22. Clinical significance of mTOR and eIF4E expression in invasive ductal carcinoma. Hu A; Sun M; Yan D; Chen K Tumori; 2014; 100(5):541-6. PubMed ID: 25343550 [TBL] [Abstract][Full Text] [Related]
23. The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia. Montaner S; Sodhi A; Servitja JM; Ramsdell AK; Barac A; Sawai ET; Gutkind JS Blood; 2004 Nov; 104(9):2903-11. PubMed ID: 15231571 [TBL] [Abstract][Full Text] [Related]
24. Akt plays a central role in sarcomagenesis induced by Kaposi's sarcoma herpesvirus-encoded G protein-coupled receptor. Sodhi A; Montaner S; Patel V; Gómez-Román JJ; Li Y; Sausville EA; Sawai ET; Gutkind JS Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4821-6. PubMed ID: 15047889 [TBL] [Abstract][Full Text] [Related]
25. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Vart RJ; Nikitenko LL; Lagos D; Trotter MW; Cannon M; Bourboulia D; Gratrix F; Takeuchi Y; Boshoff C Cancer Res; 2007 May; 67(9):4042-51. PubMed ID: 17483315 [TBL] [Abstract][Full Text] [Related]
26. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers. Pourdehnad M; Truitt ML; Siddiqi IN; Ducker GS; Shokat KM; Ruggero D Proc Natl Acad Sci U S A; 2013 Jul; 110(29):11988-93. PubMed ID: 23803853 [TBL] [Abstract][Full Text] [Related]
27. Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Bais C; Van Geelen A; Eroles P; Mutlu A; Chiozzini C; Dias S; Silverstein RL; Rafii S; Mesri EA Cancer Cell; 2003 Feb; 3(2):131-43. PubMed ID: 12620408 [TBL] [Abstract][Full Text] [Related]
28. Rapamycin blocks production of KSHV/HHV8: insights into the anti-tumor activity of an immunosuppressant drug. Nichols LA; Adang LA; Kedes DH PLoS One; 2011 Jan; 6(1):e14535. PubMed ID: 21264294 [TBL] [Abstract][Full Text] [Related]
29. Novel Gemini-vitamin D3 analog inhibits tumor cell growth and modulates the Akt/mTOR signaling pathway. O'Kelly J; Uskokovic M; Lemp N; Vadgama J; Koeffler HP J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):107-16. PubMed ID: 16777406 [TBL] [Abstract][Full Text] [Related]
30. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Hsieh AC; Costa M; Zollo O; Davis C; Feldman ME; Testa JR; Meyuhas O; Shokat KM; Ruggero D Cancer Cell; 2010 Mar; 17(3):249-61. PubMed ID: 20227039 [TBL] [Abstract][Full Text] [Related]
31. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1. Zang C; Eucker J; Liu H; Müller A; Possinger K; Scholz CW Cancer Lett; 2013 Oct; 339(2):288-97. PubMed ID: 23200668 [TBL] [Abstract][Full Text] [Related]
33. KSHV G-protein coupled receptor vGPCR oncogenic signaling upregulation of Cyclooxygenase-2 expression mediates angiogenesis and tumorigenesis in Kaposi's sarcoma. Medina MV; D Agostino A; Ma Q; Eroles P; Cavallin L; Chiozzini C; Sapochnik D; Cymeryng C; Hyjek E; Cesarman E; Naipauer J; Mesri EA; Coso OA PLoS Pathog; 2020 Oct; 16(10):e1009006. PubMed ID: 33057440 [TBL] [Abstract][Full Text] [Related]
34. Novel cellular genes essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus. Raggo C; Ruhl R; McAllister S; Koon H; Dezube BJ; Früh K; Moses AV Cancer Res; 2005 Jun; 65(12):5084-95. PubMed ID: 15958552 [TBL] [Abstract][Full Text] [Related]
35. Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. Pati S; Cavrois M; Guo HG; Foulke JS; Kim J; Feldman RA; Reitz M J Virol; 2001 Sep; 75(18):8660-73. PubMed ID: 11507211 [TBL] [Abstract][Full Text] [Related]
36. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science. Dezube BJ; Sullivan R; Koon HB J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. El-Chaâr D; Gagnon A; Sorisky A Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836 [TBL] [Abstract][Full Text] [Related]
38. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Mita MM; Mita A; Rowinsky EK Cancer Biol Ther; 2003; 2(4 Suppl 1):S169-77. PubMed ID: 14508096 [TBL] [Abstract][Full Text] [Related]